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The Relationship Between Uncertainty in Illness and Anxiety in Patients With 
Cancer 
Naima Vera 
ABSTRACT 
Anxiety is a common problem for patients with cancer. Anxiety may have a 
negative impact on decision making and overall emotional well being of patients 
and may be related to the uncertainties faced by people with cancer. This study 
examined the relationship between uncertainty in illness and anxiety in patients 
with cancer. 
The sample consisted of 30 patients, predominantly males (n=23), being 
treated as outpatients in the Clinical Research Unit at a National Cancer Institute 
designated cancer center in Florida. After agreeing to participate, patients 
completed the State-Trait Anxiety Inventory as well as Mishel‟s Uncertainty in 
Illness Scale.  
Participants‟ ages ranged from 21 to 86, with a mean age of 64 years. 
Forty percent of the patients completed high school, 30% had some college 
education and almost 30% had a bachelor‟s degree or higher. Almost 47% of the 
sample had melanoma, other patients had renal cancer (n=3), or pancreatic 
cancer (n=2), acute myeloid leukemia (n=2), sarcoma (n=2), lung cancer (n=2), 
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myeloma (n=2), chronic myeloid leukemia (n=1), glioblastoma (n=1), and rectal 
cancer (n=1). Seventy percent of the patients had stage IV disease. 
The results of the study showed a significant positive relationship between 
uncertainty and both state anxiety (r=0.52, p=0.00.) and trait anxiety (r=0.61, 
p=0.000). A significant positive relationship was also found between the 
uncertainty subscale of ambiguity and both, state anxiety (r=0.538, p=0.002) and 
trait anxiety (r=0.56, p=0.001). Both state anxiety (r=0.39, p=0.034) and trait 
anxiety (r=0.64, p=0.000) were positively related to the uncertainty subset of 
inconsistency. 
Although the sample size was small and not demographically diverse, the 
findings of this study are supportive of previous studies. The implications of this 
study in nursing are significant because they examine two emotional aspects that 
evidently exist among cancer patients, and that very likely cause distress to this 
population. The findings of this study suggest that additional focus in uncertainty 
and anxiety should take place in the clinical outpatient setting.
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Chapter One Introduction 
Cancer represents the second most common cause of death in the 
Western world (American Cancer Society, 2008). Despite the progress in 
medicine, cancer is often considered a synonym of death, pain and suffering 
(Powe & Finne, 2003). Cancer is not considered a single event but a permanent 
condition with ongoing ambiguity, or uncertainty, delayed effects of the disease 
and its treatments and concurrent psychological issues (Zebrack, 2000).   
A diagnosis of cancer is a life changing and potentially fatal event that can 
be associated with feelings of uncertainty (Shaha, Cox, Talman, & Kelly, 2008) 
leading to anxiety. Notions of uncertainly concerning the cancer experience have 
been associated with anxiety (Decker et al., 2007) in that 48% of lymphoma 
patients reported levels of anxiety high enough to be diagnosed with an anxiety 
disorder (Stark et al., 2002).  
Mishel (1988) defined uncertainty in illness as the inability to determine 
the meaning of illness-related events. Uncertainty is a component of all illness 
experiences and it is believed to affect psychosocial adaptation and outcomes of 
disease (McCormick, 2002).  High levels of uncertainty are related to high 
emotional distress, anxiety and depression (McCormick, 2002).  
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Anxiety can be defined as a state of uneasiness to a potential threat that is 
inconsistent with the expected events (Bay & Algase, 1999) and can be 
associated with feelings of fear, dread, and uneasiness (National Cancer Society, 
2008). The threat of cancer may elicit this state of uneasiness. Higher anxiety 
levels have been found in cancer patients who are aware of their diagnosis 
compared to a group of patients without awareness (Tavoli, Mohagheghi, 
Montazer, Roshan, Rasool, and Omidvari, 2007).  
Problem Statement 
Defining the relationship between uncertainty and anxiety is important 
because it can lead to further studies that focus on the simultaneous 
management of uncertainty and anxiety as well as their impact on quality of life 
(QOL). Uncertainty remains one of the single greatest source of stress for people 
affected by a life-threatening illness such as cancer (Santacroce, 2002). Stark et 
al. studied anxiety in 178 patients with lymphoma, renal cell carcinoma, 
melanoma and plasma cell dyscrasia. They found that 48% of these patients had 
levels of anxiety high enough to qualify for anxiety disorder. According to 
Pitcealthy et al. (2009) most cancer patients report distress within the first year of 
diagnosis and up to 40% develop anxiety which impairs the quality of life for the 
patient.  
Uncertainty and anxiety are experienced by most patients with cancer due 
to the inability to determine the meaning of illness-related events and to the 
potential threat that the cancer diagnosis poses. Although anxiety and 
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uncertainty are important factors and are commonly experienced by cancer 
patients, little research was found during the review of literature that focused on 
evaluating a relationship between the two. The purpose of this study was to 
examine the relationship between uncertainty in illness and anxiety in patients 
with cancer. 
If a relationship between uncertainty and anxiety is defined, there is a 
possibility that decreasing uncertainty may in turn decrease anxiety. Although 
things may never be normal after a patient is diagnosed with cancer, oncology 
nurse practitioners should have effective and clear communication as a simple 
but successful way to reduce uncertainty, and simultaneously decrease anxiety. 
A relationship between uncertainty and anxiety may give rise to future research 
to reduce uncertainty and anxiety during all stages of cancer.  
Research Questions 
The following questions guided this study: 
1. Is there a significant positive relationship between uncertainty and trait anxiety 
in outpatients in a cancer center who have been diagnosed with cancer? 
2. Is there a significant positive relationship between uncertainty and state 
anxiety in outpatients in a cancer center who have been diagnosed with cancer? 
3. Are there significant positive relationships between uncertainty in illness 
subscales and either state or trait anxiety? 
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Definitions of Terms 
Uncertainty in illness. Uncertainty is an inability to determine meaning in 
illness situations (Mishel, 1988). Uncertainty in cancer is directly related to not 
knowing about cancer. Uncertainty is influenced by factors that change from 
person to person. Therefore, the definition of uncertainty in illness is individual 
and specific to one person. The term itself is directly related to not knowing. The 
concept is taken a step further when referring to uncertainty in cancer. 
Uncertainty remains one of the single greatest source of stress for people 
affected by a life-threatening illness such as cancer (Santacroce, 2002). 
Anxiety. Two types of anxiety have been defined; state anxiety and trait 
anxiety. State anxiety is a temporary condition in response to a stressful 
situation, like a cancer diagnosis. Trait anxiety is defined as a more general and 
long-standing quality (Spielberger, 1983).    
Anxiety is a reaction to stress due to the thought of negative 
consequences of the illness. Anxiety is a threat to homeostasis, a presence of 
impending change, a sense of loss, uneasiness or increased apprehension. 
Anxiety has been defined as a heightened state of uneasiness to a potential 
threat that is inconsistent with the expected events and results when there is a 
mismatch between the next likely event and the actual event (Bay & Algase, 
1999). 
Anxiety can interfere with personal growth, physical health and behavior. 
Clinical expression of anxiety may include increasing tension, worry, fright, 
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trembling, quivering voice, arousal and jitters (Bay & Algase, 1999). Many times 
the source of anxiety is unknown; however in cancer, the source of anxiety is 
related to the impact of the diagnosis in one‟s life.    
Significance to Nursing 
This study may contribute to the future enhancement of the clinical 
treatment of anxiety in cancer patients in any stage of disease and treatment 
modality.  In addition, this study may contribute to the limited research in 
uncertainty and anxiety of cancer patients.  Good clinical guidelines are currently 
lacking in the identification and treatment of uncertainty, and early recognition 
may help reduce the associated anxiety. Enhanced awareness of the potential 
problems associated with the uncertainty frequently experienced by cancer 
patients may motivate nurses to develop better management strategies.  
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Chapter Two Review of Literature 
This chapter presents the background for the study. A review of relevant 
research literature in uncertainty and anxiety is presented. This is followed by a 
summary and implications for nursing. Finally, gaps in the literature are 
presented.  
Uncertainty in Illness 
Uncertainty in illness has been studied using several different frameworks.  
Mishel (1981) has widely studied the concept of uncertainty in cancer using the 
Mishel‟s Uncertainty in Illness Scale (MUIS) to measure uncertainty. The scale 
presents four major factors which are: ambiguity, unpredictability, complexity and 
inconsistencies. Many have studied the concept of uncertainty in cancer and 
have based their studies on Mishel‟s Theory of Uncertainty in Illness. Mishel‟s 
model suggests coping is initiated to reduce uncertainty, especially when danger 
is perceived.  In addition, coping is initiated to maintain the belief in a positive 
outcome when uncertainty is appraised as an opportunity.   
 A study conducted by Wallace et al., (2007) explored the three main 
domains established by Mishel, which include: uncertainty about disease and 
treatment, danger appraisal, and opportunity appraisal. The investigators used 
older men with prostate cancer undergoing watchful waiting as their population. 
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The defining features of uncertainty about disease and treatment were found to 
be: few signals to monitor progression of disease, lack of physical discomforts 
made it hard to believe that the cancer was there, lack of symptoms created 
uncertainty as cancer was perceived as related to pain and suffering, physician 
unable to tell how fast tumors grow, elevated PSA levels do not always indicate 
cancer, stable levels do not always indicate stable disease. Danger appraisals 
were found to be: treatment decision making was found as an appraisal of 
danger, lack of clear guideline and multiple alternatives, the newness of watchful 
waiting made them wonder if it was aggressive enough.  
Interestingly, Wallace‟s (2007) study also noted that while uncertainty was 
consistently present in all patients after making the decision of watchful waiting, 
this offered the opportunity to manage their uncertainty by continuing to work, 
self-caring, keeping options open, using alternative medicine and praying, 
imagining cancer as small, by envisioning the smallness of their localized tumor, 
watch and wait provided an option to aggressive therapy or surgery that many 
times lead to poor outcomes and poor quality of life. 
Mishel‟s re-conceptualization of Uncertainty in Illness Theory has also 
been used to study and explain the relationship between uncertainty and post 
traumatic stress syndrome. Lee (2006) conducted a study to examine the 
relationship between uncertainty and post traumatic stress syndrome in young 
adults, survivors of childhood cancer. It was found that post traumatic stress 
syndrome develops and is adopted by the survivors of childhood cancer as a 
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maladaptive strategy to manage uncertainty when they lack of sufficient 
resources for coping with the challenges of survivorship. Furthermore, avoidance 
and arousal, which are two symptom clusters of post traumatic stress disorder, 
were found to be related to uncertainty. Once again the study suggests that 
providing health related information appropriately (without ambiguity, low 
complexity, and no unpredictably) could potentially help alleviate or decrease 
uncertainty in cancer survivors.  
 Uncertainty throughout the cancer experience. Uncertainty does not 
diminish beyond diagnosis; therefore, uncertainty should continue to be 
addressed even throughout survivorship (Decker, Haase & Bell, 2007). In their 
study, Decker, et.al., (2007) used Michel‟s uncertainty model to study uncertainty 
in cancer patients. They found that there are no significant differences in the 
overall level of uncertainty among the newly diagnosed, diagnosed 1 to 4 years 
and diagnosed more than 5 years. However, newly diagnosed patients scored 
high uncertainty for future pain, unpredictable illness course, staff responsibility, 
and concerns about caring for themselves. Those diagnosed 1 - 4 years and 5 or 
more years, had high uncertainty about the multiple meanings of communication 
from the doctors. Those diagnosed 5 years or more had higher uncertainty about 
knowing what was wrong, had more unanswered questions and had higher 
uncertainty regarding the probability of successful treatment. Their study 
emphasizes the importance of certainty to provide open communication beyond 
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diagnosis and the cancer treatment phase. In addition, results suggests that the 
type of information needed changes during each stage of the cancer experience.  
  Mishel, along with Gil, Belyea, Germino, Porter, and Clayton (2006) 
reported significant benefit in providing cognitive behavioral strategies and self 
help manuals to increase recurrence free breast cancer survivor knowledge. 
Mishel et al. (2006) conducted a study that found that even after 10 months of no 
interventions, these women were able to integrate the changes and skill gained 
during intervention even without the direct guidance.  
  This same patient sample was used to gather data regarding triggers of 
uncertainty (memories, feelings, concerns) about cancer recurrence and physical 
symptoms from treatment side effects.  The study found that hearing about 
someone else‟s cancer and pains, was the most frequent trigger of uncertainty.  
It was also found that in both Caucasian and African Americans, the most 
frequent symptoms linked to long-term treatment side effects were fatigue, joint 
stiffness, and pain.   In 2006, Lee studied post traumatic stress disorder and 
uncertainty. This study found that there is a relationship between post traumatic 
stress disorder (PTSD) and uncertainty suggesting that cancer survivors adopt 
PTSD as a way to manage uncertainty.  
 Ethnic differences and uncertainty. Ethnic differences were also evaluated 
in research. Caucasian women were found to be more likely than African 
American women to report that their fears of recurrence were triggered by 
hearing about someone else‟s cancer while for African American the most 
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common trigger was new symptoms. The study also concluded that uncertainty 
remains after cancer diagnosis and treatment and that these survivors 
experienced triggers of uncertainty on a regular basis, with an average of 2 
triggers per month (Gil, et al., 2006).  
 The study helps to better understand that during cancer survivorship 
uncertainty should still be identified, monitored and managed along with 
emotional distress. Giving specific information about symptoms that are 
commonly experienced as late effects of treatment is important in reducing 
anxiety in patients. Education, counseling and support should be offered to help 
patients cope with unexpected encounters that trigger uncertainty of recurrence 
as these triggers are often found in daily occurrences.  
 Germino et al., (2007) found that ethnic differences exist in the 
relationship of uncertainty to a number of quality of life and coping variables. In a 
study of female breast cancer survivors (Gil et al., 2006), the investigators found 
that the women were not only benefiting from being able to identify and use 
information about their illness, but they were also able to integrate this 
information without direct guidance. 
 Communication. In a study by Clayton, Mishel and Belyea (2006) the 
concept of uncertainty and how communication with health care providers may 
help women reduce uncertainty and improve both emotional and cognitive well-
being was investigated. A positive association was found between health care 
provider communication and thoughts of recurrence. More than half of the 
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sample indicated that they were unable to achieve their desired decision-making 
role with health care providers. An interesting finding that health care providers 
might be offering information that contributes to thoughts of recurrence is a 
possibility raised by the study.  
Anxiety in Cancer   
According to Stark et al. (2002) anxiety is a response to a threat and given 
that cancer is a threat, many patients with cancer experience anxiety. Stark et al. 
(2002) studied anxiety in 178 patients with lymphoma, renal cell carcinoma, 
melanoma and plasma cell dyscrasia. They found that 48% of these patients had 
levels of anxiety high enough to qualify for anxiety disorder. This study also found 
that the most accurate screening questionnaires for anxiety include the State-
Trait Anxiety Inventory and the Hospital Anxiety and Depression Scale. 
Symptoms of anxiety are common among cancer patients and therefore, it is 
appropriate to screen for anxiety and understand the impact of anxiety in cancer 
patients‟ quality of life. 
Tavoli et al. (2007) found that psychological distress is higher in patients 
who are aware of their cancer diagnosis when compared to those patients who 
are not aware of their diagnosis. Tavioli et al. conducted a cross-sectional study 
to examine anxiety in 142 patients with gastrointestinal cancer patients and 
investigated whether the knowledge of cancer diagnosis affects patients‟ 
psychosocial status. Of these cancer patients, 52% were not aware of their 
diagnosis and 48% were aware of having cancer. The mean anxiety score was 
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7.6 (SD=+/-4.5) and 47.2 % of the patients had high anxiety score. A significant 
difference was noted between those who knew their diagnosis (anxiety means 
score of 9.1) versus those who did not know (anxiety means score of 6.3); P 
<0.001. After performing regression analysis it was found that anxiety showed 
strong relationships with knowledge of cancer diagnosis.  
It is important to be aware of the role that intrusive cognition plays in 
anxiety and adaptation of the experience of living with a cancer diagnosis. In a 
study conducted by Whitaker et al. (2007) patients with cancer classified as 
anxious reported intrusive or disturbing imagery significantly more times than 
non-anxious patients (P<0.01). Anxious patients also reported more intrusive 
thoughts (P<0.01) and more intrusive memories (P<0.05). No correlation was 
found between intrusive cognition and disease stage (P=0.98). The study also 
found that intrusive imagery in these cancer patients is a factor in psychological 
morbidity.  
Patient symptom reporting is important and significant in guiding treatment 
and diagnosis of cancer. A study published by Leventhal, Schmitz, Rabin, and 
Ward (2001) found that anxiety is positively related with vague symptom 
reporting and not related to concrete symptom reporting in patients undergoing 
chemotherapy treatment. The study findings suggest that trait anxiety was 
positively related with over reporting of symptoms and supports that although 
trait-anxious individuals pay closer attention to symptoms as they occur, the 
symptom reporting is often vague rather than concrete (Leventhal et al., 2001). 
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Studies have found that psychological interventions at time of diagnosis 
may promote adjustment in newly diagnosed cancer patients. Pitceathly et al. 
(2008) studied 313 patients newly diagnosed with cancer. These patients were 
free of anxiety or depressive disorders at the time of diagnosis. The patients 
were separated in high risk of developing anxiety and low risk. Patients were 
then randomized to receive immediate psychological interventions, delayed 
psychological intervention or no psychological intervention. The study reports 
that twelve months after intervention, patients at high risk who received 
intervention were less likely to develop an anxiety disorder. In the low risk group 
no differences were noted.  
Gattellari, Butow, and Tattersall (2001) studied 233 patients with cancer 
who were visiting their oncologist for first time. They found that anxiety levels 
significantly decreases pre consultation and post consultation when patients 
preferred and perceived roles matched. Nevertheless, they found that most 
cancer patients fail to achieve their desired level of involvement in their care.  
Their result also supported that less involvement than patient preferred, appears 
to be more detrimental to anxiety levels than more involvement than preferred.  
Summary of Literature Reviewed 
  In regard to uncertainty, the review of literature suggests that the concept 
of uncertainty is a dynamic one that is mostly determined by the present situation 
and its factors (Mishel, 1981). In regard to anxiety, the literature proposes that 
patients diagnosed with cancer and aware of their disease have higher levels of 
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anxiety (Tavoli et al., 2008). The relationship between uncertainty and anxiety 
was not directly addressed in the literature reviewed.  
 Literature reviewed related to anxiety and psychological distress in cancer 
patients is higher in cancer patients aware of their diagnosis (Tavoli et al., 2008). 
The study encourages early implementation of methods to reduce anxiety after 
giving a cancer diagnosis and constant assessment of anxiety is crucial in the 
care of cancer patients. Whitaker et al., (2007) concluded that intrusive 
cognitions were associated with person‟s own experience of having cancer and 
that intrusive cognition was most strongly associated with anxiety. The study 
makes providers aware of the role that intrusive cognition plays in anxiety and 
adaptation of the experience of living with a cancer diagnosis. 
 In uncertainty, the literature findings focused on assessment and 
management of uncertainty in cancer patients. Decker and colleges (2007) 
clearly suggest that uncertainty is related to quality of life and psychological 
health outcomes. Furthermore, their study found that uncertainty is present in all 
stages of illness and can be reduced using effective communication and taking 
into consideration ethnic and cultural differences. Decker and colleagues 
demonstrated that the degree of uncertainty changes during each stage of the 
cancer experience and that it continues throughout survivorship. Interestingly, 
Clayton et al., (2006) found that there is a possibility that healthcare providers 
contribute to thoughts of recurrence, increasing patients‟ feelings of uncertainty.   
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 To identify a relationship between uncertainty and anxiety would be 
valuable to nursing and to cancer patients. If a positive relationship is found 
between the two, it would be possible to do further research in the simultaneous 
assessment and management of both co-morbidities and the impact that one has 
on the other.  The literature reviewed emphasized the importance of uncertainty 
and anxiety in health outcomes and quality of life, justifying further research in 
this area. 
Implications for Nursing 
 The field of oncology has much to gain from further studies in uncertainty 
and anxiety in patients diagnosed with cancer. Ways to manage uncertainty have 
been thoroughly studied in many areas and stages of cancer. The studies 
reviewed consistently demonstrate that healthcare providers can contribute to 
decreasing uncertainty in our patients. For example, the data analyzed by Gil et 
al. (2006) demonstrated that a group of female breast cancer survivors were able 
to integrate the changes and skills gained during guided uncertainty intervention 
even without the direct guidance. If a positive relationship between uncertainty 
and anxiety is defined, further research can be done in the management of 
anxiety in oncology. In nursing, understanding the concept of uncertainty and 
anxiety and its possible relationship is important because proper management of 
these can allow patients to participate in their decision making process 
throughout their illness as well as it can eliminate a huge barrier to patients‟ 
participation in their care.  
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Gaps in the Literature 
There is a noticeable gap in the literature regarding assessment and 
management of anxiety specifically in patients with cancer. Much is said about 
anxiety in general, but little is related specifically to the oncology population and 
healthcare providers. The current literature does have plenty of information about 
uncertainty in illness, and specifically in cancer. The literature has studies about 
uncertainty in the different stages of a cancer experience; at diagnosis, during 
treatment and in survivorship. Studies on managing uncertainty are lacking.  
Finding a relationship between uncertainty and anxiety may be able to fill 
some gaps, specifically regarding anxiety and cancer. The relationship may also 
encourage further research in the simultaneous assessment and management of 
both, uncertainty and anxiety. 
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Chapter Three Methods 
A descriptive cross-sectional design was used to identify the relationship 
between uncertainty and anxiety in patients with cancer.  A literature review on 
uncertainty and anxiety in patients with cancer sustains the belief that a positive 
relationship between uncertainty and anxiety might exist. The study design, tools 
used, procedure and statistical analysis are discussed in this chapter.   
Setting and Sample 
The sample for this study was gathered from patients in the Clinical 
Research Unit (CRU) outpatient setting of a National Cancer Institute designated 
center in southwest Florida. Thirty patients were accrued to the study. 
Patients enrolled in the study met the following inclusion criteria: over 
eighteen years old, able to read, write and understand English, pathologically 
diagnosed with cancer for at least 4 weeks prior to study enrollment as located 
on pathology report in patients‟ medical record, aware of cancer diagnosis for at 
least 4 weeks prior to study enrollment as documented by physician in patients‟ 
medical record. 
The following criteria excluded patients: being an inpatient at the time of 
encounter, being unaware of their cancer diagnosis, having untreated and/or 
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symptomatic brain metastasis or psychiatric diagnosis. Information about 
psychiatric diagnosis was abstracted from the medical record.  
Instruments 
Mishel’s Uncertainty in Illness Scale (MUIS). The Uncertainty in Illness 
Scale (Mishel, 1983) was used to measure uncertainty (Appendix A). The MUIS 
is a 33-item self-administered tool designed to measure acuity of uncertainty in 
illness. This instrument has four subscales: ambiguity or cues about the state of 
illness being vague and indistinct, tending to overlap (13 items, coefficient of .91), 
complexity or cues about treatment and system of care are multiple, intricate and 
varied (7 items, coefficient alpha of .75), inconsistency or information that 
changes frequently or is not in accord with information previously received (5 
items, coefficient  alpha of .71), and unpredictability (6 items, coefficient alpha of 
.70). Scores for ambiguity can range from 13 to 65. Scores for inconsistency can 
range from 7 to 35. Scores for complexity can range from 7 to 25. Scores for 
unpredictability can range from 5 to 25. 
To complete the questionnaire, subjects selected the degree to which they 
agreed or disagreed with thirty-three statements related to uncertainty. Items are 
scored on a five point Likert-type scale that ranges from „strongly agree‟ to 
„strongly disagree‟. The highest possible total score is one hundred and sixty with 
higher scores indicating greater levels of uncertainty.  
State Trait Anxiety Inventory (STAI). The State Trait Anxiety Inventory 
(STAI) was used to measure anxiety (Appendix A & B). It is a self administered 
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tool that differentiates between temporary condition of anxiety (state) and a long 
standing anxious quality (trait). The STAI has a total of 40 questions; 20 testing 
state and 20 testing trait. Each question has four possible answers. Items are 
scored on a 4-point Likert-type scale, with response going from 1 (not at all) to 4 
(very much so). The highest score is 160; the lowest is 40. High scores indicate 
higher levels of anxiety. The alpha coefficients for the state anxiety scale ranges 
from 0.83 to 0.94. The trait anxiety scale has a median alpha coefficient of 0.90 
(Spielberger, 1983).  
Procedures 
The study was approved by the Scientific Review Committee of the cancer 
center and the University of South Florida Institutional Review Board. The 
investigator identified the patients via the medical record for inclusion criteria.  
Once identified, patients were invited to participate and the study was explained. 
Patients who agreed to participate signed an informed consent form (Appendix 
F). The demographic data was retrieved via the medical record and recorded on 
a hard copy data form. The participants complete two study questionnaires 
during the research encounter with the primary investigator.  The research 
encounter required approximately 30 minutes after consent process.  Patients 
were instructed that the interviews could be stopped at any time.  The interviews 
were held in a private area in the clinical research unit. Personal identifiers were 
removed from all study related paperwork except for the informed consent form. 
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Original copies of the signed ICF and all study related paperwork are kept in the 
study binder and securely locked.  
Data Analysis 
The research questions that guided this study were: Is there a significant 
positive relationship between uncertainty and trait anxiety in outpatients in a 
cancer center who have been diagnosed with cancer?, Is there a significant 
positive relationship between uncertainty and state anxiety in outpatients in a 
cancer center who have been diagnosed with cancer?, Are there significant 
positive relationships between uncertainty in illness subscales and either state or 
trait anxiety.  
Descriptive statistics, including means, standard deviations, frequencies 
and percentages, were used to describe the patient sample. To address the 
questions, Pearson correlation were used to determine the relationship of 
uncertainty and state and trait anxiety, as well as the relationship between 
uncertainty subscales and state and trait anxiety. 
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Chapter Four Results, Discussion and Conclusions 
This chapter presents the findings of the study to include: results, 
discussion of the results, implications for nursing, conclusion and suggestions for 
future research. 
Results 
Demographic data. The sample consisted of 30 patients with ages ranging 
from 21 to 86 years, with a mean age of 64. Twenty three males participated in 
the study while only 7 females agreed to participate (Table 1).  
Table 1  
 
Frequency and Percent of Participants by Gender 
 
Gender 
 
Frequency 
 
Percentage 
 
Female 
 
7 
 
23.3 
 
Male 
 
23 
 
76.7 
 
Educational background of the sample was varied. Three percent of the 
sample did not complete high school, 40% had a high school diploma, 30% 
completed some college, almost 17% had a bachelor‟s degree, 2 patients had a 
doctoral degree and 1 had a master‟s degree (Table 2).  
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Table 2  
 
Frequency and Percent of Participants by Level of Education 
 
Level of Education 
 
Frequency 
 
Percentage 
 
Some High School 
 
1 
 
3.3 
High School Diploma 12 40.0 
Some College 9 30.0 
Bachelor‟s 5 16.37 
Master‟s 1 3.3 
Doctorate 2 6.7 
 
Almost 47% of the sample had melanoma, other patients had renal (n=3), 
pancreatic (n=2), acute myelogenous leukemia (n=2), sarcoma (n=2), lung 
cancer (n=2), myeloma (n=2), chronic myelogenous leukemia (n=1), glioblastoma 
(n=1), and rectal cancer (n=1). Seventy percent of the patients had stage IV 
disease. (Table 3).  
 
 
 
 
 
 
 
 23 
 
Table 3  
 
Frequency and Percent of Participant’s Diagnosis and Stage 
 
Diagnosis 
 
Frequency 
 
Percent 
 
Melanoma 
 
14 
 
46.7 
Renal 3 10.0 
Pancreatic 2 6.7 
Acute myelogenous              
leukemia 
2 6.7 
Sarcoma 2 6.7 
Lung 2 6.7 
Myeloma 2 6.7 
Chronic myelogenous 
leukemia 
1 3.3 
Glioblastoma 1 3.3 
Rectal 1 3.3 
Stage   
     I 2 0.1 
     III 4 0.1 
     IV 21 0.7 
UNKNOWN 3 0.1 
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Time since diagnosis ranged from less than 6 months to over 5 years 
(Table 4). Twenty percent of the patient had been diagnosed between 1-2 years 
from time of enrollment. Thirteen percent had been diagnosed within 6 months, 
and almost 17 % of the sample was diagnosed within 3 to 4 years. Seventeen 
percent of the sample was diagnosed within the last 6 months to a year. 
Seventeen percent of the sample was diagnosed more than five years from the 
time of enrollment, and only 10% of the patients were diagnosed for 2 to 3 years.  
Table 4  
 
Frequency and Percent of Participants’ Time Since Diagnosis and State Anxiety, 
Trait Anxiety and MUIS Mean Scores and Standard Deviations by Time of 
Diagnosis. 
 
Time since diagnosis 
 
Frequency  
(%) 
 
State Anxiety 
Mean 
(Standard 
Deviation) 
 
Trait Anxiety 
Mean 
(Standard 
Deviation) 
 
MUIS 
Mean 
(Standard 
Deviation) 
 
< 6 months 
 
4 (13.3) 
 
33.8 (12.1) 
 
29.8 (7.4) 
 
90.5 (13.2) 
6 months to 1year 5 (16.7) 33.0 (9.9) 30.6 (8.3) 84.0 (8.9) 
1 to 2 years 6 (2.0) 29.8 (10.0) 28.3 (10.6) 83.8 (11.4) 
2 to 3 years 3 (10.0) 35.0 (7.0) 33.3 (2.5) 80.3 (6.1) 
3 to 4 years 5 (16.7) 36.8 (11.3) 35.8 (9.7) 94.4 (7.6) 
4 to 5 years 2 (6.7) 21.0 (1.4) 24.0 (.0) 81.5 (9.2) 
5 years or more 5 (16.7) 28.6 (8.6) 33.6 (10.5) 86.0 (9.5) 
Total 30 (100.0) 31.8 (9.7) 31.2 (8.6) 86.4 (11.4) 
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State-Trait Anxiety. The State-Trait Anxiety Inventory was used to 
measure state and trait anxiety. The mean score of the state anxiety inventory 
was 31.8 with a standard deviation of 9.7. The mean score of the trait anxiety 
inventory was 31.2 with a standard deviation of 8.6 (Table 4). No relationship 
was found between anxiety and age, gender, diagnosis, stage, educational level 
and time since diagnosis. Nevertheless, there was a trend towards higher mean 
scores in state anxiety, and trait anxiety in patients diagnosed within three to 
fours years (Table 4).   
Table 5 
 
Correlations of Uncertainty with State and Trait Anxiety 
  
R 
 
P 
 
State Anxiety 
 
0.52 
 
0.003 
 
Trait Anxiety 
 
 
0.61 
 
0.000 
 
Uncertainty in illness. Mishel‟s Uncertainty in Illness Scale was used to 
measure uncertainty. No significant correlation was found between uncertainty 
and age, gender, diagnosis, stage, educational level and time of diagnosis. 
Interestingly, patients diagnosed within three to four years had slightly higher 
mean scores on the MUIS (Table 4).  
The subscales ambiguity, complexity, inconsistency and unpredictability 
were also measured. The mean score for ambiguity was 31.1 with a standard 
deviation of 11.4. The mean score for complexity was 27.2, with a standard 
deviation of 4.2. The mean score for inconsistency was 13.8, with a standard 
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deviation of 4.8. Finally, the mean score for predictability was 12.3 with a 
standard deviation of 2.6. 
Relationship between uncertainty and anxiety. A significant positive 
relationship was found between ambiguity and state (r=0.53, p=0.002) and trait 
anxiety (r=0.56, p=0.001) (Table 6, 7). A significant positive relationship was also 
found between inconsistency and state (r=0.389, p=0.034) and trait anxiety 
(r=0.64, p=0.000) (Table 6, 7). No relationship was found between state- trait 
anxiety and complexity and unpredictability (Table 6, 7). Trait anxiety was 
significantly higher in people with higher levels of uncertainty (r=0.61, p=0.000) 
(Table 5). State anxiety was also positively related with higher levels of anxiety 
(r=0.52, p=0.003) (Table 5).   
Table 6  
 
Correlation of Four Factors of Uncertainty and State Anxiety 
 
 
 
R 
 
P 
 
Ambiguity 
 
0.54 
 
0.002 
 
Complexity 
 
-0.26 
 
0.162 
 
Inconsistency 
 
0.39 
 
0.034 
 
Unpredictability 0.07 
 
0.716 
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Table 7 
 
Correlation of Four Factors of Uncertainty and Trait Anxiety 
 
 R P 
 
Ambiguity 
 
0.562 
 
0.001 
 
Complexity 
 
-0.298 
 
0.109 
 
Inconsistency 
 
0.642 
 
0.000 
 
Unpredictability 
 
-0.064 
 
0.735 
 
 
Discussion 
Sample. Participants were recruited from the Clinical Research Unit at an 
NCI designated cancer center. Data was collected during the month of April 
2009. The lack of heterogeneity was a limitation of the sample. The majority of 
the sample accrued to the study had stage IV cancer and was receiving 
experimental therapy in the clinical research unit, in an outpatient basis. The 
median age was 66, and the majority of the patients completed high school. The 
sample was predominantly male, and almost half of the sample was diagnosed 
with melanoma. Over 13% of the sample had been diagnosed within 5 months of 
enrollment and more than 16% were aware of their diagnosis for 5 years or 
longer. 
The results of this study cannot be generalized to other cancer patients 
receiving standard therapy for an early stage disease. The anxiety and 
uncertainty levels of the sample being studied could largely differ from the levels 
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of a cancer population with a better prognosis and receiving standard therapy 
with curative intent. Also, the sample was significantly dominated by males, so 
the representation of females was low. 
State-Trait Anxiety. In a study conducted on healthy and normal working 
adults (Spielberger, et al., 1983), the mean score for state anxiety was 35.7 and 
standard deviation of 10.4. Based on Spielberger‟s results, the anxiety levels 
found in the present study sample were slightly lower than in healthy adults.  
Spielberger‟s STAI is a very well tested instruments ad has been used 
previously in patients with cancer. It is difficult to speculate reasons why anxiety 
levels in this study sample were lower than the one found by Spielberger in 
healthy adults. It is possible that this study sample, being predominantly stage VI 
cancer patients, had resigned themselves to their illness and accepted it as life-
limiting, therefore decreasing their anxiety levels. Conversely, being in the 
Clinical Research Unit might have made them feel hopeful, and therefore, less 
anxious. Further study is needed to evaluate unmeasured variable to include 
unequal gender representation, spirituality and hope.  
Uncertainty in illness. Uncertainty scores were calculated using the four 
factors to include ambiguity, complexity, inconsistency and unpredictability. The 
total mean score for uncertainty was obtained by adding the scores of all four 
factors. The mean total score found in the study sample was 86.4 with a standard 
deviation of 11.4. The total scale mean score in Mishel‟s composite cancer 
population had a total mean score of 69.46 with a standard deviation of 15.9 
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(Mishel, 1987). This higher uncertainty mean score in the present sample may be 
due to the receiving of experimental treatment with little information regarding the 
treatment outcomes. It is possible that patients who choose experimental 
treatment are different from other patients in some unknown way. Perhaps, these 
patients feel more hopeful that experimental therapy will help, but at the same 
time more uncertain about it. 
It is also important to remark that due to the amount of intricate and varied 
information provided during experimental therapy, one would expect that the 
complexity mean score of the study sample would be higher than the mean score 
of a generalized cancer population undergoing standard of care treatment. 
Nevertheless, Mishel‟s composite cancer population had complexity mean score 
(25.33 with standard deviation of 5.3) comparable to the mean score found on 
this study (27.17 with a standard deviation of 4.202).  
The Relationship between Uncertainty in Illness and Anxiety 
The findings of this study suggest that the levels of state and trait anxiety 
are higher among cancer patients with higher levels of uncertainty. This means 
that there is a positive relationship between uncertainty and state and trait 
anxiety. It is important to note that, unexpectedly, trait anxiety shows a stronger 
relationship to uncertainty than state anxiety.  However, the study sample was 
small and further research is needed. 
The results of this study also found that two out of four subcategories 
(factors) of uncertainty, ambiguity and inconsistency, were positively related to 
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both, state and trait anxiety. Both subcategories, ambiguity and inconsistency, 
demonstrated a stronger relationship with trait anxiety. Given that trait anxiety 
was found to have a stronger relationship with general uncertainty, as well as 
with specific factors of uncertainty (ambiguity and inconsistency), the results 
could suggest that patients who tend to have higher anxiety at all times (trait) 
may be less able to tolerate uncertainty. Nevertheless, it is state anxiety that will 
most likely be amenable to interventions by nurse practitioners. 
Among the cancer population multiple studies have looked at the concepts 
of uncertainty and anxiety. Nevertheless, the relationship between the two 
concepts has not been widely studied. The only relevant study in the literature 
(Kaminsky, 1991) showed similar results.  
Implications for nursing 
The findings of this study have implications for nursing. Assessment of 
both uncertainty and anxiety at baseline as well as during patients‟ cancer should 
be incorporated in the clinical practice. Given that a positive relationship was 
found between uncertainty and anxiety, assessing uncertainty can predict the 
presence of higher or lower level of anxiety, and vice versa. The study supports 
that uncertainty and anxiety are present in the oncology population, and may 
cause additional emotional distress.  
A significant part of the nurses‟ role is to be patient advocates and have a 
holistic approach in caring for patients. Research should be conducted further in 
the areas of uncertainty and anxiety in order to develop guidelines for effective 
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management of uncertainty. Furthermore, studies can research the effect of 
proper uncertainty management in anxiety and the incorporation of such 
managements in nursing education. 
Conclusion 
Anxiety levels were found to be higher in patients with higher levels of 
uncertainty. The data suggests that this relationship is stronger between 
uncertainty and trait anxiety. Two of the four uncertainty factors, ambiguity and 
inconsistency, were found to be positively related to anxiety. Significant 
relationships between anxiety or uncertainty and age, gender, diagnosis, stage or 
educational level were not found.  
Recommendation for future research 
The findings of this study suggest the need for development of studies to 
develop evidence-based clinical guidelines to better manage uncertainty and 
anxiety. It would also be useful to study the effects that decreasing ambiguity and 
inconsistency would have on anxiety levels.  
The study could potentially be replicated with a larger sample, to include 
inpatients and an equal sample of males and females. It would also be useful to 
compare two groups, one undergoing standard of care therapy versus a group on 
experimental therapy. Experimental interventions to decrease ambiguity and 
inconsistencies could be designed and implemented to see their impact in the 
levels of anxiety. A study could also be conducted to include the practitioner‟s 
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perception of the patients‟ level of uncertainty and anxiety versus the patients‟ 
actual levels.  
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Appendix A: Mishel Uncertainty in Illness Scale (MUIS) 
MISHEL UNCERTAINTY IN ILLNESS SCALE – ADULT FORM 
 
INSTRUCTIONS: 
          Please read each statement. Take your time and think about what each statement  
          says. Then place a “X” under the column that most closely measures how you  
          are feeling  TODAY. If you agree with a statement, then you would mark under 
          either “Strongly Agree” or “Agree”. If you disagree with a statement, then mark  
under either “Strongly Disagree” or “Disagree”. If you are undecided about how you feel, then mark 
under “Undecided” for that statement. Please respond to every  
          statement. 
 
1. I don’t know what is wrong with me. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
 
     _______           ______          ______            ______                 ______ 
 
2. I have a lot of questions without answers. 
  
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
 
     _______           ______          ______            ______                 ______ 
 
      3.   I am unsure if my illness is getting better or worse. 
  
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
 
     _______           ______          ______            ______                 ______ 
 
4.  It is unclear how bad my pain will be. 
 
Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                   (4)                 (3)                    (2)                        (1) 
 
     _______            ______          ______            ______                 ______ 
 
5. The explanations they give about my condition seem hazy to me. 
 
 Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
          (5)                    (4)                 (3)                    (2)                        (1) 
 
     _______            ______          ______            ______                 ______ 
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Appendix A: Mishel Uncertainty in Illness Scale (MUIS) (Continued) 
 6.    The purpose of each treatment is clear to me. 
 
  Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
             (5)                  (4)                 (3)                    (2)                        (1) 
 
         _______         ______          ______            ______                 ______ 
 
 7.    When I have pain, I know what this means about my condition. 
 
   Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
              (5)                  (4)                 (3)                    (2)                        (1) 
 
          _______         ______          ______            ______                 ______ 
 
 
  8.    I do not know when to expect things will be done to me. 
 
   Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
              (5)                 (4)                 (3)                    (2)                        (1) 
 
         _______         ______          ______            ______                 ______ 
 
   9.   My symptoms continue to change unpredictably. 
 
   Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
              (5)                 (4)                 (3)                    (2)                        (1) 
 
          _______        ______          ______            ______                 ______ 
 
10.  I understand everything explained to me. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
     
11.  The doctors say things to me that could have many meanings. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
   
12.  I can predict how long my illness will last. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
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Appendix A: Mishel Uncertainty in Illness Scale (MUIS) (Continued) 
13. My treatment is too complex to figure out. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
14. It is difficult to know if the treatments or medications I am getting are helping.  
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
15. There are so many different types of staff; it’s unclear who is responsible for what. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
16. Because of the unpredictability of my illness, I cannot plan for the future. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
17. The course of my illness keeps changing. I have good and bad days. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
18. It’s vague to me how I will manage my care after I leave the hospital. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
19. I have been given many differing opinions about what is wrong with me. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
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Appendix A: Mishel Uncertainty in Illness Scale (MUIS) (Continued) 
20. It is not clear what is going to happen to me. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
 
21. I usually know if I am going to have a good or bad day. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
22. The results of my tests are inconsistent. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
23. The effectiveness of the treatment is undetermined. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
24. It is difficult to determine how long it will be before I can care for myself.  
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
25. I can generally predict the course of my illness. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
26. Because if the treatment, what I can do and cannot do keeps changing. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
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Appendix A: Mishel Uncertainty in Illness Scale (MUIS) (Continued) 
27. I’m certain they will not find anything else wrong with me. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
28. The treatment I am receiving has a known probability of success. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
29. They have not given me a specific diagnosis. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
 
30. My physical distress is predictable; I know when it is going to get better or worse. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
31. I can depend on the nurses to be there when I need them. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
 
32. The seriousness of my illness has been determined. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
 
           _______         ______          ______            ______                 ______ 
  
 
33. The doctors and nurses use everyday language so I can understand what they are saying. 
 
    Strongly Agree      Agree        Undecided         Disagree        Strongly Disagree 
               (5)                  (4)                 (3)                    (2)                        (1) 
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Appendix B: State Anxiety Inventory  
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Appendix C: Trait Anxiety Inventory 
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Appendix D: Letter of Approval from Moffitt Scientific Review Committee 
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Appendix D: Letter of Approval from Moffitt Scientific Review Committee 
(Continued) 
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Appendix E: Letter of Approval from USF Institutional Review Board 
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Appendix E: Letter of Approval from USF Institutional Review Board (Continued) 
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Appendix F: Informed Consent Form 
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Appendix F: Informed Consent Form (Continued) 
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Appendix F: Informed Consent Form (Continued) 
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Appendix F: Informed Consent Form (Continued) 
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Appendix F: Informed Consent Form (Continued) 
 
